| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A global view of regulatory networks in lung cancer: An approach to understand homogeneity and heterogeneity
|
Lu, Jiapei
|
|
2017
|
42 |
C |
p. 31-38
|
artikel
|
| 2 |
ALK alterations and inhibition in lung cancer
|
Le, Tri
|
|
2017
|
42 |
C |
p. 81-88
|
artikel
|
| 3 |
Editorial Board & Publication Information
|
|
|
2017
|
42 |
C |
p. CO2
|
artikel
|
| 4 |
Genome analyses identify the genetic modification of lung cancer subtypes
|
Zhang, Yong
|
|
2017
|
42 |
C |
p. 20-30
|
artikel
|
| 5 |
Genomic mechanisms of transformation from chronic obstructive pulmonary disease to lung cancer
|
Wang, Diane C.
|
|
2017
|
42 |
C |
p. 52-59
|
artikel
|
| 6 |
New strategies for targeting drug combinations to overcome mutation-driven drug resistance
|
Wang, Linyan
|
|
2017
|
42 |
C |
p. 44-51
|
artikel
|
| 7 |
Piercing the “armor” of lung cancer with genome medicine
|
Gu, Jianqin
|
|
2017
|
42 |
C |
p. 1-3
|
artikel
|
| 8 |
RETRACTED: Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer
|
Shi, Lin
|
|
2017
|
42 |
C |
p. 4-12
|
artikel
|
| 9 |
Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy
|
Wu, Duojiao
|
|
2017
|
42 |
C |
p. 13-19
|
artikel
|
| 10 |
Smyd3-associated regulatory pathways in cancer
|
Giakountis, Antonis
|
|
2017
|
42 |
C |
p. 70-80
|
artikel
|
| 11 |
TGFΒ-induced transcription in cancer
|
Cantelli, Gaia
|
|
2017
|
42 |
C |
p. 60-69
|
artikel
|
| 12 |
Tomorrow’s genome medicine in lung cancer
|
Wang, Diane C.
|
|
2017
|
42 |
C |
p. 39-43
|
artikel
|
Tijdschrift beschrijving